ACTIVE

PHARMA CHEMICALS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result350,3 k €-49,5 %over 1 year
Gross margin2,2 M €+3,6 %over 1 year
Equity1 M €+50,9 %over 1 year
Workforce22,5 ETP+7,1 %over 1 year

Identity

Source · BCE/KBO

PHARMA CHEMICALS is a Public limited company incorporated in 2016. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Braine-le-Château. It employs on average 22,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0662.547.315
Incorporation
13/09/2016
Legal form
Public limited company
Registered office
Parc Industriel(W-B) 19
1440 Braine-le-Château · WallonieSee on map
Contributed capital
805 150,00 €
Latest accounts
31/12/2025
Average workforce
22,5 ETP
Joint committees (1)
  • 207
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 9 filings

Trend over 9 financial years

20252024202320222021
Income statement
Gross margin2,2 M €2,1 M €1,3 M €937,5 k €1,1 M €
EBITDA961,4 k €1 M €212,9 k €48,3 k €299,4 k €
Operating result616,3 k €845,5 k €147,3 k €-367,1 k €98,7 k €
Net result350,3 k €693,7 k €114,4 k €-456,9 k €-50,3 k €
Balance sheet
Equity1 M €688,3 k €-5,4 k €-99,8 k €402,2 k €
Total assets3,2 M €3 M €2,5 M €2,3 M €2,2 M €
Cash403,9 k €558,1 k €564,1 k €368,8 k €17,8 k €
Debts2,2 M €2,3 M €2,5 M €2,4 M €1,8 M €
Other
Workforce22,5 ETP21,0 ETP18,5 ETP16,9 ETP16,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 17 ended

Active mandates

PROCURAM

Director · 0830.958.616

Represented by Michaël Hillaert

Active

Ended mandates

Pharmentum

Director · since 24 avril 2019 · until 29 mai 2025 · 0699.939.132

Represented by Joeri Van den Acker

Ended
TLYS

Director · since 24 avril 2019 · until 29 mai 2025 · 0712.615.151

Represented by Tieme LEYSEELE

Ended
TLYS

Managing director · since 24 avril 2019 · until 29 mai 2025 · 0712.615.151

Represented by Tieme LEYSEELE

Ended
François Van Sull

Director · since 11 octobre 2017 · until 27 mai 2021

Ended

Other companies at this address

Parc Industriel(W-B) 19 1440 Braine-le-Château
CompanyCBE no.
Pharma Chemicals France● Active
0741.620.032

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/08/202601/09/202530/08/202431/08/202330/08/202202/02/2021
General meeting30/06/202629/05/202530/05/202430/06/202327/05/202201/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202631/08/2026FrenchPDF
Abridged model31/12/202429/05/202501/09/2025FrenchPDF
Abridged model31/12/202330/05/202430/08/2024FrenchPDF
Abridged model31/12/202230/06/202331/08/2023FrenchPDF
Abridged model31/12/202127/05/202230/08/2022FrenchPDF
Abridged model31/12/202001/02/202102/02/2021FrenchPDF
Micro model31/12/201928/05/202031/08/2020FrenchPDF
Micro model31/12/201829/05/201928/06/2019FrenchPDF
Micro model31/12/201714/06/201816/07/2018FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 17 ended

Active mandates

PROCURAM

Director · 0830.958.616

Represented by Michaël Hillaert

Active

Ended mandates

Pharmentum

Director · since 24 avril 2019 · until 29 mai 2025 · 0699.939.132

Represented by Joeri Van den Acker

Ended
TLYS

Director · since 24 avril 2019 · until 29 mai 2025 · 0712.615.151

Represented by Tieme LEYSEELE

Ended
TLYS

Managing director · since 24 avril 2019 · until 29 mai 2025 · 0712.615.151

Represented by Tieme LEYSEELE

Ended
François Van Sull

Director · since 11 octobre 2017 · until 27 mai 2021

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates30/03/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring10/03/2025
    DEMISSIONS, NOMINATIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring22/04/2024
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates04/02/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/12/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares23/05/2019
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Registered office03/04/2018
    SIEGE SOCIAL
    PDF
  • Mandates23/11/2017
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025350,3 k €↓
  2. 2024
    Annual accounts 2024693,7 k €↑
  3. 2023
    Annual accounts 2023114,4 k €↑
  4. 2022
    Annual accounts 2022-456,9 k €↓
  5. 2021
    Annual accounts 2021-50,3 k €↓
  6. 2020
    Annual accounts 2020442,4 k €↑
  7. 2019
    Annual accounts 2019-326,2 k €↑
  8. 2018
    Annual accounts 2018-410,9 k €↓
  9. 2017
    Annual accounts 2017-123,1 k €
  10. 13/09/2016
    IncorporationPublic limited company